BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9221050)

  • 1. [Temporary changes and permanent changes in the erythrocyte blood-group antigens in malignant hemopathies].
    Hafner V; Coatmelec M; Niculescu R
    Rom J Intern Med; 1996; 34(3-4):183-8. PubMed ID: 9221050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of blood group-like antigens on the T lymphocytes of acute leukaemia patients in remission.
    Pullen S; Hersey P
    Clin Exp Immunol; 1980 Feb; 39(2):403-10. PubMed ID: 6966993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia.
    Irvine AE; Magill MK; Somerville LE; McMullin MF
    Exp Hematol; 1998 May; 26(5):435-9. PubMed ID: 9590661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytomorphology of acute mixed leukemia].
    Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of ABO blood groups in childhood acute leukemia.
    Alavi S; Ashraf H; Rashidi A; Hosseini N; Abouzari M; Naderifar M
    Pediatr Hematol Oncol; 2006 Dec; 23(8):611-7. PubMed ID: 17065136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
    Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
    Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
    Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shifts in expression of immunological cell markers in relapsed acute leukemia.
    Tomová A; Babusíková O
    Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
    Bader P; Niemeyer C; Weber G; Coliva T; Rossi V; Kreyenberg H; Gerecke A; Biondi A
    Eur J Haematol; 2004 Jul; 73(1):25-8. PubMed ID: 15182334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of refractory anemia with excess of blasts (RAEB) having weakened expression of B blood group antigen].
    Munekata R; Miyazawa I; Matsuzaki H; Yoshino K; Hirano M; Mukôyama H; Nariuchi H
    Rinsho Ketsueki; 1990 Dec; 31(12):1960-4. PubMed ID: 2079733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Discrepant results of ABO type of red cells and serum in a patient with acute myelogenous leukemia].
    Fujita A; Fujisawa S; Hyo R; Kuwabara H; Yamazaki E; Tomita N; Ishigatsubo Y
    Rinsho Ketsueki; 2008 Jan; 49(1):51-4. PubMed ID: 18277597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of carbonic anhydrase II in hematological malignancies.
    Leppilampi M; Koistinen P; Savolainen ER; Hannuksela J; Parkkila AK; Niemelä O; Pastoreková S; Pastorek J; Waheed A; Sly WS; Parkkila S; Rajaniemi H
    Clin Cancer Res; 2002 Jul; 8(7):2240-5. PubMed ID: 12114426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
    Olaru D; Campos L; Flandrin P; Nadal N; Duval A; Chautard S; Guyotat D
    Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
    Skovlund VR
    APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal residual disease testing in acute leukemia by flow cytometry immunophenotyping: prognostic significance.
    Ruiz-Argüelles GJ; Fernández-Lara D; Estrada-Gómez R; Manzano C; Ruiz-Delgado GJ; Pérez-Romano B; Ruiz-Argüelles A
    Lab Hematol; 2007; 13(1):22-6. PubMed ID: 17353179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.